P-selectin glycoprotein ligand-1
P-selectin glycoprotein ligand-1 (PSGL-1) is a protein that in humans is encoded by the SELPLG gene. It is a type of cell adhesion molecule (CAM) that plays a crucial role in the immune system's response to injury or infection.
Structure
PSGL-1 is a membrane protein that is typically found on the surface of white blood cells, including neutrophils, monocytes, and lymphocytes. It is a high molecular weight, heavily glycosylated protein. The protein has a unique structure, with a long, extended shape that allows it to interact with other proteins on the surface of endothelial cells.
Function
The primary function of PSGL-1 is to mediate the adhesion of circulating leukocytes to endothelial cells, which is a critical step in the immune response. This is achieved through interaction with selectins, particularly P-selectin, on the surface of the endothelial cells. This interaction allows the leukocytes to roll along the endothelial surface, a process known as leukocyte rolling. This is the first step in the process of leukocyte extravasation, which allows the leukocytes to exit the bloodstream and enter the tissues where they can combat infection or injury.
Clinical significance
Alterations in the function or expression of PSGL-1 have been implicated in a number of diseases, including inflammatory diseases, autoimmune diseases, and cancer. For example, in rheumatoid arthritis, increased expression of PSGL-1 has been observed on the surface of leukocytes, which may contribute to the inflammation and tissue damage seen in this disease. In cancer, some tumor cells have been found to express PSGL-1, which may allow them to adhere to the endothelium and spread to other parts of the body, a process known as metastasis.
Research
Research is ongoing to better understand the role of PSGL-1 in health and disease, and to develop therapies that can modulate its function. For example, drugs that block the interaction between PSGL-1 and P-selectin could potentially be used to treat inflammatory diseases or prevent cancer metastasis.
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD